Real-time blood glucose CGM patch market seen topping $11.5 billion by 2030

The real-time blood glucose continuous glucose monitoring patch market is projected to rise from $7.05 billion in 2025 to $11.57 billion by 2030, driven by diabetes growth, remote monitoring and telehealth adoption. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Real-time blood glucose CGM patches give people with diabetes continuous glucose readings without frequent finger-prick testing. - The market’s growth points to rising demand for more convenient, patient-friendly diabetes management tools. - Remote monitoring and telehealth are becoming more important as healthcare systems look for ways to manage chronic disease outside clinics.

What happened: - The Business Research Company released its Real-Time Blood Glucose CGM Patch Global Market Report 2026, covering market size, trends and forecasts through 2035. - The report estimates the market will grow from $7.05 billion in 2025 to $7.77 billion in 2026. - The report projects the market will reach $11.57 billion by 2030, implying a 10.5% CAGR over the forecast period. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region during the forecast period. - The report includes regional coverage for Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

The details: - A real-time blood glucose CGM patch is a wearable device that measures glucose levels in interstitial fluid beneath the skin and provides immediate feedback. - The device helps users track blood sugar patterns, spot fluctuations early and adjust insulin or diet more quickly. - The market’s recent expansion has been driven by rising diabetes prevalence, the limits of traditional finger-prick testing, greater adoption of wearable medical devices, stronger demand for self-monitoring and the digitalization of healthcare services. - Future growth is expected to come from AI-driven glucose prediction tools, tighter telehealth integration, preventive diabetes care, broader remote patient monitoring and supportive reimbursement policies. - Key trends include continuous glucose monitoring wearables, needle-free glucose tracking, real-time glucose alerts, longer-lasting wearable patches and improved sensor accuracy. - The report says its 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - The report offers a free sample at sample report. - The full report is available at full market report.

Between the lines: - The market outlook reflects a broader shift from episodic testing to continuous, connected diabetes care. - Telehealth demand is rising as patients and providers want ongoing data sharing instead of in-person check-ins. - The American Hospital Association said in February 2025 that the U.S. could face a shortage of up to 86,000 physicians by 2036, underscoring why remote care tools may gain more traction. - The report frames reimbursement and digital care integration as practical enablers, not just technology upgrades.

What's next: - The market is expected to keep expanding as CGM patches become more integrated with telehealth and remote monitoring workflows. - Adoption could accelerate if AI prediction tools improve outcomes and reimbursement policies remain supportive. - Asia-Pacific’s faster growth could make the region a bigger strategic focus for manufacturers and healthcare providers.

The bottom line: - Real-time CGM patches are moving from a niche diabetes tool toward a broader connected-care platform, and the market data points to sustained double-digit growth over the next several years.